annual operating profit:
-$143.09M-$88.97M(-164.38%)Summary
- As of today (June 17, 2025), MLTX annual operating income is -$143.09 million, with the most recent change of -$88.97 million (-164.38%) on December 31, 2024.
- MLTX annual operating profit is now -164.38% below its all-time high of -$54.12 million, reached on December 31, 2023.
Performance
MLTX Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
-$47.48M+$2.10M(+4.23%)Summary
- As of today (June 17, 2025), MLTX quarterly operating income is -$47.48 million, with the most recent change of +$2.10 million (+4.23%) on March 31, 2025.
- Over the past year, MLTX quarterly operating profit has dropped by -$27.66 million (-139.58%).
- MLTX quarterly operating profit is now -657.67% below its all-time high of -$6.27 million, reached on September 30, 2021.
Performance
MLTX quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$170.76M-$27.66M(-19.33%)Summary
- As of today (June 17, 2025), MLTX TTM operating income is -$170.76 million, with the most recent change of -$27.66 million (-19.33%) on March 31, 2025.
- Over the past year, MLTX TTM operating profit has dropped by -$109.74 million (-179.87%).
- MLTX TTM operating profit is now -422.48% below its all-time high of -$32.68 million, reached on June 30, 2021.
Performance
MLTX TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
MLTX Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -164.4% | -139.6% | -179.9% |
| 3 y3 years | - | -197.9% | -211.1% |
| 5 y5 years | - | -45.3% | -422.5% |
MLTX Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -164.4% | at low | -267.2% | +4.2% | -328.4% | at low |
| 5 y | 5-year | -164.4% | at low | -657.7% | +4.2% | -422.5% | at low |
| alltime | all time | -164.4% | at low | -657.7% | +4.2% | -422.5% | at low |
MLTX Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$47.48M(-4.2%) | -$170.76M(+19.3%) |
| Dec 2024 | -$143.09M(+164.4%) | -$49.58M(+15.0%) | -$143.09M(+31.8%) |
| Sep 2024 | - | -$43.11M(+41.0%) | -$108.54M(+38.4%) |
| Jun 2024 | - | -$30.58M(+54.3%) | -$78.40M(+28.5%) |
| Mar 2024 | - | -$19.82M(+31.9%) | -$61.01M(+12.7%) |
| Dec 2023 | -$54.12M | -$15.03M(+15.8%) | -$54.12M(-3.0%) |
| Sep 2023 | - | -$12.98M(-1.6%) | -$55.79M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$13.19M(+2.0%) | -$57.58M(-7.2%) |
| Mar 2023 | - | -$12.93M(-22.5%) | -$62.05M(-4.6%) |
| Dec 2022 | -$65.06M | -$16.70M(+13.0%) | -$65.06M(+34.5%) |
| Sep 2022 | - | -$14.77M(-16.3%) | -$48.37M(+21.3%) |
| Jun 2022 | - | -$17.65M(+10.7%) | -$39.86M(-27.4%) |
| Mar 2022 | - | -$15.94M(+154.4%) | -$54.89M(+40.9%) |
| Sep 2021 | - | -$6.27M(-80.8%) | -$38.95M(+19.2%) |
| Jun 2021 | - | -$32.68M | -$32.68M |
FAQ
- What is MoonLake Immunotherapeutics annual operating income?
- What is the all time high annual operating profit for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual operating profit year-on-year change?
- What is MoonLake Immunotherapeutics quarterly operating income?
- What is the all time high quarterly operating profit for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly operating profit year-on-year change?
- What is MoonLake Immunotherapeutics TTM operating income?
- What is the all time high TTM operating profit for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM operating profit year-on-year change?
What is MoonLake Immunotherapeutics annual operating income?
The current annual operating profit of MLTX is -$143.09M
What is the all time high annual operating profit for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual operating income is -$54.12M
What is MoonLake Immunotherapeutics annual operating profit year-on-year change?
Over the past year, MLTX annual operating income has changed by -$88.97M (-164.38%)
What is MoonLake Immunotherapeutics quarterly operating income?
The current quarterly operating profit of MLTX is -$47.48M
What is the all time high quarterly operating profit for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly operating income is -$6.27M
What is MoonLake Immunotherapeutics quarterly operating profit year-on-year change?
Over the past year, MLTX quarterly operating income has changed by -$27.66M (-139.58%)
What is MoonLake Immunotherapeutics TTM operating income?
The current TTM operating profit of MLTX is -$170.76M
What is the all time high TTM operating profit for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM operating income is -$32.68M
What is MoonLake Immunotherapeutics TTM operating profit year-on-year change?
Over the past year, MLTX TTM operating income has changed by -$109.74M (-179.87%)